CELZ

SEC source: 0001477932-25-001159 · form4.xml · nonDerivative · entry 2

Finger Michael H. · CIK 0001898925 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351

SEC source: 0001477932-25-001159 · form4.xml · nonDerivative · entry 1

Finger Michael H. · CIK 0001898925 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,101

SEC source: 0001477932-23-004914 · form4.xml · nonDerivative · entry 4

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,209

SEC source: 0001477932-23-004914 · form4.xml · nonDerivative · entry 3

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,009

SEC source: 0001477932-23-004914 · form4.xml · nonDerivative · entry 2

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,809

SEC source: 0001477932-23-004914 · form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,509

SEC source: 0001477932-22-008858 · form4.xml · nonDerivative · entry 4

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,087

SEC source: 0001477932-22-008858 · form4.xml · nonDerivative · entry 3

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,887

SEC source: 0001477932-22-008858 · form4.xml · nonDerivative · entry 2

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,087

SEC source: 0001477932-22-008858 · form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,087

SEC source: 0001477932-22-007299 · form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,087

SEC source: 0001477932-22-007311 · form4.xml · nonDerivative · entry 1

Finger Michael H. · CIK 0001898925 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,502

SEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 5

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,087

SEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 4

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,087

SEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 3

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,087

SEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 2

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,587

SEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,087

SEC source: 0001477932-22-004377 · form4.xml · nonDerivative · entry 1

Finger Michael H. · CIK 0001898925 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,502

SEC source: 0001477932-22-004177 · form4.xml · nonDerivative · entry 3

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,087

SEC source: 0001477932-22-004177 · form4.xml · nonDerivative · entry 2

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,087

SEC source: 0001477932-22-004177 · form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,087

SEC source: 0001477932-22-003708 · form4.xml · nonDerivative · entry 1

Finger Michael H. · CIK 0001898925 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,502

SEC source: 0001477932-22-000692 · form4.xml · derivative · entry 1

Dickerson Donald · CIK 0001674942 · Director · CFO & Sr. VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,237

Underlying: Common Stock · 53,237 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The options vests immediately as to 25% of the shares subject to the option, and in three equal installments of 25% of the shares subject to the option on each of the next three annual anniversary dates of the grant date.

SEC source: 0001477932-22-000693 · form4.xml · derivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,580

Underlying: Common Stock · 58,580 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The options vests immediately as to 25% of the shares subject to the option, and in three equal installments of 25% of the shares subject to the option on each of the next three annual anniversary dates of the grant date.

SEC source: 0001477932-21-004848 · form4.xml · nonDerivative · entry 3

Ichim Thomas · CIK 0001429928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,529,522

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.0305. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001477932-21-004848 · form4.xml · nonDerivative · entry 2

Ichim Thomas · CIK 0001429928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,979,522

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.031. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001477932-21-004848 · form4.xml · nonDerivative · entry 1

Ichim Thomas · CIK 0001429928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,479,522

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.03 to $0.030521, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.

SEC source: 0001477932-21-004706 · form4.xml · derivative · entry 1

Patel Amit Nilkanth · CIK 0001674929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000,000

Underlying: Common Stock · 5,000,000 shares

Expires 2031-07-15

SEC source: 0001477932-21-004705 · form4.xml · derivative · entry 1

Dickerson Donald · CIK 0001674942 · Director · CFO & Sr. VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000,000

Underlying: Common Stock · 5,000,000 shares

Expires 2031-07-15

SEC source: 0001477932-21-004707 · form4.xml · derivative · entry 1

Ichim Thomas · CIK 0001429928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000,000

Underlying: Common Stock · 5,000,000 shares

Expires 2031-07-15

SEC source: 0001477932-21-004334 · form4.xml · derivative · entry 4

Ichim Thomas · CIK 0001429928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000,000 shares

Expires 2030-12-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001477932-21-004334 · form4.xml · nonDerivative · entry 2

Ichim Thomas · CIK 0001429928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,879,552

F1 · security: Reflects 1,120,448 shares of common stock withheld by issuer at a market price of $0.0357 per share to fund the cashless exercise of 10,000,000 shares of common stock acquired upon exercise of the Warrant identified in Table II.

SEC source: 0001477932-21-004334 · form4.xml · nonDerivative · entry 1

Ichim Thomas · CIK 0001429928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001477932-21-000138 · form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Entity

Disclosed balance after: 113,474,233

F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $50,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0016 on December 9, 2020. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

F1 · price: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $50,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0016 on December 9, 2020. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

SEC source: 0001477932-21-000137 · form4.xml · nonDerivative · entry 1

CREATIVE MEDICAL HEALTH INC. · CIK 0001538398 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,474,233

F1 · kind: The shares of common stock were issued to the Reporting Person in satisfaction of a $50,000 payment owed to the Reporting Person under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0016 on December 9, 2020.

F1 · price: The shares of common stock were issued to the Reporting Person in satisfaction of a $50,000 payment owed to the Reporting Person under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0016 on December 9, 2020.

SEC source: 0001477932-20-007594 · form4.xml · derivative · entry 1

Patel Amit Nilkanth · CIK 0001674929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000,000

Underlying: Common Stock · 10,000,000 shares

Expires 2030-12-28

SEC source: 0001477932-20-007595 · form4.xml · derivative · entry 1

Dickerson Donald · CIK 0001674942 · Director · CFO & Sr. VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000,000

Underlying: Common Stock · 10,000,000 shares

Expires 2030-12-28

SEC source: 0001477932-20-007593 · form4.xml · derivative · entry 1

Ichim Thomas · CIK 0001429928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000,000

Underlying: Common Stock · 10,000,000 shares

Expires 2030-12-28

SEC source: 0001477932-20-005720 · form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Entity

Disclosed balance after: 68,831,376

F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $40,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0027 on September 28, 2020, and then doubled because such trading price was below $0.01. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

F1 · price: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $40,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0027 on September 28, 2020, and then doubled because such trading price was below $0.01. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $40,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0027 on September 28, 2020, and then doubled because such trading price was below $0.01. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

SEC source: 0001477932-20-005721 · form4.xml · nonDerivative · entry 1

CREATIVE MEDICAL HEALTH INC. · CIK 0001538398 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,831,376

F1 · kind: The shares of common stock were issued to the Reporting Person in satisfaction of a $40,000 payment owed to the Reporting Person under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0027 on September 28, 2020, and then doubled because such trading price was below $0.01.

F1 · price: The shares of common stock were issued to the Reporting Person in satisfaction of a $40,000 payment owed to the Reporting Person under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0027 on September 28, 2020, and then doubled because such trading price was below $0.01.

SEC source: 0001104659-20-070295 · tm2021915-2_4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Entity

Disclosed balance after: 26,503,334

F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $75,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $75,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

SEC source: 0001104659-20-070294 · tm2021915-1_4.xml · nonDerivative · entry 1

CREATIVE MEDICAL HEALTH INC. · CIK 0001538398 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,503,334

F1 · kind: The shares of common stock were issued by the issuer to the Reporting Person in exchange for the cancellation of $75,000 of accrued obligations owed to the Reporting Person for management services provided to the Issuer.

SEC source: 0001104659-20-022930 · tm209399-2_4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Entity

Disclosed balance after: 6,766,492

F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $45,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $45,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

SEC source: 0001104659-20-022928 · tm209399-1_4.xml · nonDerivative · entry 1

CREATIVE MEDICAL HEALTH INC. · CIK 0001538398 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,766,492

F1 · kind: The shares of common stock were issued by the issuer to the Reporting Person in exchange for the cancellation of $45,000 of accrued obligations owed to the Reporting Person for management services provided to the Issuer.

SEC source: 0001104659-19-072558 · tm1925194d1_form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Entity

Disclosed balance after: 677,473,616

F1 · kind: The shares of common stock were issued to Creative Medical Health, Inc. ("CMH") as a $50,000 partial payment of the $100,000 payment owed to CMH under Section 3.2 of the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and CMH. Mr. Warbington is the President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

F1 · ownership.nature: The shares of common stock were issued to Creative Medical Health, Inc. ("CMH") as a $50,000 partial payment of the $100,000 payment owed to CMH under Section 3.2 of the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and CMH. Mr. Warbington is the President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

SEC source: 0001104659-19-072563 · tm1925194d2_form4.xml · nonDerivative · entry 1

CREATIVE MEDICAL HEALTH INC. · CIK 0001538398 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 677,473,616

F1 · kind: The shares of common stock were issued to the Reporting Person as a $50,000 partial payment of the $100,000 payment owed to the Reporting Person under Section 3.2 of the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person.

SEC source: 0001104659-19-060169 · tv531792_form4.xml · nonDerivative · entry 1

CREATIVE MEDICAL HEALTH INC. · CIK 0001538398 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,473,616

F1 · kind: The shares of common stock were issued by the issuer to the Reporting Person in exchange for the cancellation of $50,000 of accrued obligations owed to the Reporting Person for management services provided to the Issuer.

SEC source: 0001104659-19-072554 · tv531793_form4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Entity

Disclosed balance after: 177,473,616

F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $50,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $50,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

SEC source: 0001144204-19-033713 · tv524786_4.xml · nonDerivative · entry 1

Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Entity

Disclosed balance after: 77,473,616

F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $60,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $60,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein.

SEC source: 0001144204-19-033715 · tv524788_4.xml · nonDerivative · entry 1

CREATIVE MEDICAL HEALTH INC. · CIK 0001538398 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,473,616

F1 · kind: The shares of common stock were issued by the issuer to the Reporting Person in exchange for the cancellation of $60,000 of accrued obligations owed to the Reporting Person for management services provided to the Issuer.